| Product Code: ETC10634565 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
China meperidine import market saw significant growth in 2024, with top exporting countries including Metropolitan France, Germany, South Korea, Japan, and the USA. The market concentration, as measured by the HHI, decreased from moderate to low in 2024, indicating a more diverse import market. The compound annual growth rate (CAGR) from 2020 to 2024 was a healthy 7.28%, with a notable growth rate of 18.83% from 2023 to 2024. This suggests a robust demand for meperidine in China and a positive outlook for the future of the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Meperidine Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Meperidine Market Revenues & Volume, 2021 & 2031F |
3.3 China Meperidine Market - Industry Life Cycle |
3.4 China Meperidine Market - Porter's Five Forces |
3.5 China Meperidine Market Revenues & Volume Share, By Pain Management, 2021 & 2031F |
3.6 China Meperidine Market Revenues & Volume Share, By Oral, 2021 & 2031F |
3.7 China Meperidine Market Revenues & Volume Share, By Hospitals, 2021 & 2031F |
4 China Meperidine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in China |
4.2.2 Growing geriatric population in China |
4.2.3 Rising awareness about pain management and healthcare services |
4.3 Market Restraints |
4.3.1 Stringent regulations on opioid medications in China |
4.3.2 Increasing preference for alternative pain management therapies |
4.3.3 High risk of addiction and abuse associated with meperidine |
5 China Meperidine Market Trends |
6 China Meperidine Market, By Types |
6.1 China Meperidine Market, By Pain Management |
6.1.1 Overview and Analysis |
6.1.2 China Meperidine Market Revenues & Volume, By Pain Management, 2021 - 2031F |
6.2 China Meperidine Market, By Oral |
6.2.1 Overview and Analysis |
6.2.2 China Meperidine Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 China Meperidine Market, By Hospitals |
6.3.1 Overview and Analysis |
6.3.2 China Meperidine Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.3 China Meperidine Market Revenues & Volume, By Home Care Settings, 2021 - 2031F |
7 China Meperidine Market Import-Export Trade Statistics |
7.1 China Meperidine Market Export to Major Countries |
7.2 China Meperidine Market Imports from Major Countries |
8 China Meperidine Market Key Performance Indicators |
8.1 Number of pain management clinics offering meperidine in China |
8.2 Prescription rates of meperidine compared to other opioid medications |
8.3 Patient satisfaction scores related to meperidine usage |
9 China Meperidine Market - Opportunity Assessment |
9.1 China Meperidine Market Opportunity Assessment, By Pain Management, 2021 & 2031F |
9.2 China Meperidine Market Opportunity Assessment, By Oral, 2021 & 2031F |
9.3 China Meperidine Market Opportunity Assessment, By Hospitals, 2021 & 2031F |
10 China Meperidine Market - Competitive Landscape |
10.1 China Meperidine Market Revenue Share, By Companies, 2024 |
10.2 China Meperidine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |